Morphologic subforms of ALCL and their correlation with immunophenotype
| Histologic subform . | CD30 . | Immunophenotype . | EMA+cases . | ALK+ cases (%) . |
|---|---|---|---|---|
| Common (classic) type* 3,10 13 | Positive | Most T/null | Majority | 60-90 |
| Giant cell-rich3,10 13 | Positive | Most T/null | Minority | 30-40 |
| Small cell11 13 | Positive (mainly large cells) | T | Most† | 100 |
| Lymphohistiocytic3,8,10 13 | Positive | T | Most† | 80-100 |
| Hodgkin-like3,10,13 65 | Positive | Null (rarely T) | Minority | ∼ 15 |
| Rare subforms | ||||
| Sarcomatoid42 | Positive | NDA | NDA | NDA |
| Neutrophil rich13,44 45 | ||||
| Eosinophil rich43 | ||||
| Signet ring15 46 |
| Histologic subform . | CD30 . | Immunophenotype . | EMA+cases . | ALK+ cases (%) . |
|---|---|---|---|---|
| Common (classic) type* 3,10 13 | Positive | Most T/null | Majority | 60-90 |
| Giant cell-rich3,10 13 | Positive | Most T/null | Minority | 30-40 |
| Small cell11 13 | Positive (mainly large cells) | T | Most† | 100 |
| Lymphohistiocytic3,8,10 13 | Positive | T | Most† | 80-100 |
| Hodgkin-like3,10,13 65 | Positive | Null (rarely T) | Minority | ∼ 15 |
| Rare subforms | ||||
| Sarcomatoid42 | Positive | NDA | NDA | NDA |
| Neutrophil rich13,44 45 | ||||
| Eosinophil rich43 | ||||
| Signet ring15 46 |